Glucocorticoid Receptor Expression Predicts Good Outcome in response to Taxane-Free, Anthracycline-Based Therapy in Triple Negative Breast Cancer

<div>Kaplan–Meier curves of (i) overall survival and (ii) relapse-free survival stratified by high and low GR IHC expression in (a) TMA #1 (<i>N</i> = 57) and (b) TMA #2 (<i>N</i> = 64).</div>

Journal of Oncology

fig4

Figure 4

Figure 4: Glucocorticoid Receptor Expression Predicts Good Outcome in response to Taxane-Free, Anthracycline-Based Therapy in Triple Negative Breast Cancer 

Figure 4 | Glucocorticoid Receptor Expression Predicts Good Outcome in response to Taxane-Free, Anthracycline-Based Therapy in Triple Negative Breast Cancer 